Evidence method
Sequential · gp.financial.deposits
0.47% · CORE · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
HTB · Dec 31, 2024
HomeTrust Bancshares, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001538263-25-000040Bank
Evidence method
Level · gp.fundamentals.cash
$279.2M · CORE · VALID
Evidence method
Sequential · gp.financial.loans
-1.31% · CORE · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History52 statesSelf-history eligible
Jun 30, 20206/6 normalizedLevel 3Sep 30, 20205/5 normalizedLevel 3Jun 30, 20215/5 normalizedLevel 3Sep 30, 20215/5 normalizedLevel 3Jun 30, 20226/6 normalizedLevel 3Sep 30, 20226/6 normalizedLevel 3Dec 31, 20226/6 normalizedLevel 3Mar 31, 20233/3 normalizedLevel 3Jun 30, 20236/6 normalizedLevel 3Sep 30, 20236/6 normalizedLevel 3Mar 31, 20243/3 normalizedLevel 3Jun 30, 20243/3 normalizedLevel 3Sep 30, 20246/6 normalizedLevel 3Dec 31, 20243/3 normalizedLevel 3Mar 31, 20255/5 normalizedLevel 3Jun 30, 20255/5 normalizedLevel 3Sep 30, 20253/3 normalizedLevel 3Dec 31, 20255/5 normalizedLevel 3Mar 31, 20265/5 normalizedLevel 3Jun 30, 20265/5 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 1.45%
- Current
- 0.47%
- Delta
- -0.98%
- Previous
- $293.5M
- Current
- $279.2M
- Delta
- -$14.3M
- Previous
- -0.04%
- Current
- -1.31%
- Delta
- -1.27%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.